ARCTIC will explore the operational feasibility of quantitative G6PD testing prior to treatment with tafenoquine or primaquine.
MMV announces the start of ARCTIC, a feasibility study of a new Plasmodium vivax malaria treatment protocol
Antimicrobials such as antimalarials are the most reported substandard and falsified medicines.
MMV echoes Fight the Fakes Alliance’s call for Global Fund Replenishment to prevent increase in falsified medicines
GSK484 raises the bar for all future preclinical candidates.